Hemochromatosis: Association of severity of iron overload with genetic markers

Blood Cells, Molecules and Diseases

Volumn 22, Issue 3, 1996, Pages 195-204

  Barton, James C ^a,c   Harmon, Leigh ^b   Rivers, Charles ^b   Acton, Ronald T ^b  

^a Brookwood Medical Center Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NONE   (United States)

Author keywords

Hemochromatosis; Human leukocyte antigen (HLA) typing; Iron; Iron overload; Microsatellite DNA markers

Indexed keywords

DNA MARKER; HLA ANTIGEN;

ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE LOCATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC MARKER; HEMOCHROMATOSIS; HLA TYPING; HUMAN; IRON OVERLOAD; PHLEBOTOMY; PRIORITY JOURNAL;

EID: 0030394593     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1996.0100     Document Type: Article

References (44)

1. 1. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 318:1355-1362, 1988.
2. 2. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice parameter for hereditary hemochromatosis. Clin Chim Acta 245:139-200, 1996.
3. 3. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 17:332-334, 1976.
4. 4. Simon M, Yaouanq J, Fauchet R, Le Gall JY, Brissot P, Bourel M. Genetics of hemochromatosis: HLA association and mode of inheritance. Ann N Y Acad Sci 526:11-22, 1988.
5. 5. Jazwinska EC, Lee SC, Webb SI, Halliday JW, Powell LW. Localization of the hemochromatosis gene close to D6S105. Am J Hum Genet 53:347-352, 1993.
6. 6. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci 27:909-916, 1982.
7. 7. Mohler DN, Wheby MS. Hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis. Am J Med Sci 292:320-324, 1986.
8. 8. Pippard, MJ. Secondary iron overload in iron metabolism in health and disease. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. London: W.B. Saunders Company Ltd. pp. 296-297, 1994.
9. 9. di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102:2108-2113, 1992.
10. 10. Mittal K, Mickey M, Singal D, Terasaki P. Serotyping for homotransplantation. XVIII. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 6:913-927, 1968.
11. 11. Grimberg J, Nawoschik S, Belluscio L, McKee R, Turck A, Eisenberg A. A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res 17:8390, 1989.
12. 12. Weber JL, Kwitek AE, May PE, Zoghbi HY. Dinucleotide repeat polymorphism at the D6S105 locus. Nucleic Acids Res 19:968, 1991.
13. 13. Williams R, Smith PM, Spicer EJF, Barry M, Sherlock S. Venesection therapy in idiopathic haemo-chromatosis: an analysis of 40 treated and 18 untreated patients. Quart J Med 38:1-16, 1969.
14. 14. Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 12:20-25, 1990.
15. 15. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am J Med 99:616-623, 1995.
16. 16. Schumacher HR Jr. Ochronosis, hemochromatosis, and Wilson's disease. In: McCarty DJ, Koopman WJ, eds. Arthritis and Allied Conditions (12th ed.). Philadelphia: Lea & Febiger. pp. 1913-1925, 1993.
17. 17. Unger RH, Foster DW. Diabetes mellitus. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology (8th ed.). Philadelphia: W. B. Saunders Co. pp. 1255-1333, 1992.
18. 18. Griffin JE, Wilson JD. Disorders of the testes and the male reproductive tract. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology (8th ed.). Philadelphia: W. B. Saunders Co. pp. 799-852, 1992.
19. 19. Olney BA. Myocardial disease. B. Restrictive myocardial disease. In: Giuliani ER, Fuster V, Gersh BJ, McGoon MD, McGoon DC, eds. Cardiology: Fundamentals and Practice (2nd ed.). St. Louis: Mosby-Year Book, Inc. pp. 1775-1791, 1991.
20. 20. SAS Users Guide. Statistics (Version 5) (SAS Institute, Cary NC, 1985).
21. 21. Woolf B. On estimating the relation between blood group and disease. Am J Hum Genet 19:251-253, 1955.
22. 22. Edwards CQ, Dadone MM, Skolnick MH, Kushner JP. Hereditary hemochromatosis. Clin Haematol 11:411-435, 1982.
23. 23. Worwood M, Raha-Chowdhury R, Dorak MT, Darke C, Bowen DJ, Burnett AK. Alleles at D6S265 and D6S105 define a haemochromatosis-specific genotype. Br J Haematol 86:963-866, 1994.
24. 24. Simon M, Le Mignon L, Fauchet R, et al. Study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet 41:89-105, 1987.
25. 25. Summers KM, Tam KS, Halliday LW, Powell LW. HLA determinants in an Australian population of hemochromatosis patients and their families. Am J Hum Genet 41:89-105, 1987.
26. 26. Crawford DHG, Powell LW, Leggett BA, et al. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 57:362-367, 1995.
27. 27. Radisky ES, Ajioka RS, Edwards CQ, Griffen LM, Kushner JP. Mapping recombinant events with molecular markers in hemochromatosis pedigrees. Cytogenet Cell Genet 67:126-128, 1994.
28. 28. Powell LW, Summers KM, Board PG, Axelsen E, Webb S, Halliday JW. Expression of hemo-chromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology 98:1625-1632, 1990.
29. 29. Gasparini P, Borgato L, Piperno A, et al. Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F. Hum Mol Genet 2:571-576, 1993.
30. 30. Yaouanq J, Perichon M, Chorney M, et al. Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE). Am J Hum Genet 54:252-263, 1994.
31. 31. Trowsdale J, Ragoussis J, Campbell RD. Map of the human MHC. Immunol Today 12:443-446, 1991.
32. 32. Raha-Chowdhury R, Bowen DJ, Stone C, et al. New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum Mol Genet 4:1869-1874, 1995.
33. 33. Beutler E, Gelbart T, West C, Kuhl W, Lee P. A strategy for cloning the hereditary hemochromatosis gene. BCMD 21:207-216, 1995.
34. 34. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 13:399-408, 1996.
35. 35. Burt MJ, Smit DJ, Pyper WR, Powell LW, Jazwinska EC. A 4.5 megabase YAC contig and physical map over the hemochromatosis gene region. Genomics 33:153-158, 1996.
36. 36. Skikne B, Baynes RD. Iron absorption. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. London: W.B. Saunders Company Ltd. pp. 151-188, 1994.
37. 37. Rothenberg BE, Voland JR. β2 knockout mice develop parenchymal iron overload: a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci USA 93:1529-1534, 1996.
38. 38. Crawford DH, Halliday JW, Summers KM, Bourke MJ, Powell LW. Concordance of iron storage in siblings with genetic hemochromatosis: evidence of a predominantly genetic effect on iron storage. Hepatology 17:833-837, 1993.
39. 39. Suda K. Hemosiderin deposition in the pancreas. Arch Pathol Lab Med 109:996-999, 1985.
40. 40. Balcerzak SP, Mintz DH, Westerman MP. Diabetes mellitus and idiopathic hemochromatosis. Am J Med Sci 255:53-62, 1968.
41. 41. Dymock IW, Cassar J, Pyk DA, Oakley WG, Williams R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of hemochromatosis. Am J Med 52:203-210, 1972.
42. 42. Stremmel W, Niederau C, Berger M, Kley HK, Kruskemper HL, Strohmeyer G. Abnormalities in estrogen, androgen, and insulin metabolism in idiopathic hemochromatosis. Ann N Y Acad Sci 526:209-223, 1988.
43. 43. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256-1262, 1985.
44. 44. Haddy TB, Castro OL, Rana SR. Hereditary hemochromatosis in children, adolescents, and young adults. Am J Pediatr Hematol Oncol 10:23-34, 1988.